Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALTM
5751
PUT
DELISTED
Arcadium Lithium plc
ALTM
| $1.85M | ﹤0.01% |
360,900
-7,120
| -2% | -$36.3K |
|
5752
Invesco S&P 500 Top 50 ETF
XLG
$10.9B
| $1.85M | ﹤0.01% |
37,051
+27,391
| +284% | +$1.35M |
|
5753
First Trust Consumer Staples AlphaDEX Fund
FXG
$232M
| $1.85M | ﹤0.01% |
28,888
+18,227
| +171% | +$1.23M |
|
|
GRAL
5754
CALL
GRAIL Inc
GRAL
$3.12B
| $1.85M | ﹤0.01% |
103,656
+34,776
| +50% | +$565K |
|
5755
CALL
Steris
STE
$22.4B
| $1.85M | ﹤0.01% |
9,000
-500
| -5% | -$110K |
|
5756
Chegg
CHGG
$85M
| $1.85M | ﹤0.01% |
1,148,941
-439,483
| -28% | -$810K |
|
5757
Community Trust Bancorp
CTBI
$1.43B
| $1.85M | ﹤0.01% |
34,862
+28,675
| +463% | +$1.57M |
|
5758
PUT
Leonardo DRS
DRS
$12.1B
| $1.85M | ﹤0.01% |
57,200
-22,900
| -29% | -$744K |
|
|
ONC
5759
PUT
BeOne Medicines Ltd
ONC
$41B
| $1.85M | ﹤0.01% |
10,000
+8,500
| +567% | +$1.74M |
|
5760
CALL
Eldorado Gold
EGO
$10.5B
| $1.85M | ﹤0.01% |
124,200
-48,000
| -28% | -$793K |
|
5761
PUT
First Trust Cloud Computing ETF
SKYY
$3.31B
| $1.85M | ﹤0.01% |
15,500
+10,300
| +198% | +$1.19M |
|
5762
CALL
Schwab US Large-Cap Growth ETF
SCHG
$62.2B
| $1.84M | ﹤0.01% |
66,200
-70,200
| -51% | -$1.92M |
|
|
RNAM
5763
CALL
DELISTED
Avidity Biosciences
RNAM
| $1.84M | ﹤0.01% |
63,400
+22,000
| +53% | +$919K |
|
|
FFIC
5764
DELISTED
Flushing Financial
FFIC
| $1.84M | ﹤0.01% |
129,065
+120,139
| +1,346% | +$1.91M |
|
|
DHIL
5765
DELISTED
Diamond Hill
DHIL
| $1.84M | ﹤0.01% |
11,881
+10,508
| +765% | +$1.68M |
|
5766
CALL
Schrodinger
SDGR
$1.3B
| $1.84M | ﹤0.01% |
95,500
+8,200
| +9% | +$159K |
|
5767
iShares MSCI Netherlands ETF
EWN
$733M
| $1.84M | ﹤0.01% |
41,339
+7,609
| +23% | +$355K |
|
|
SII
5768
CALL
Sprott
SII
$3.14B
| $1.84M | ﹤0.01% |
43,600
-54,000
| -55% | -$2.38M |
|
5769
Universal Insurance Holdings
UVE
$1.19B
| $1.84M | ﹤0.01% |
87,303
+39,792
| +84% | +$833K |
|
5770
CALL
iShares Russell Mid-Cap Growth ETF
IWP
$21.2B
| $1.84M | ﹤0.01% |
14,500
-400
| -3% | -$50.9K |
|
5771
PUT
Morgan Stanley Direct Lending Fund
MSDL
$1.29B
| $1.84M | ﹤0.01% |
88,900
+23,200
| +35% | +$475K |
|
5772
CALL
Rentokil
RTO
$11.9B
| $1.84M | ﹤0.01% |
72,500
+6,900
| +11% | +$175K |
|
|
EQLT
5773
iShares MSCI Emerging Markets Quality Factor ETF
EQLT
$12.7M
| $1.84M | ﹤0.01% |
77,821
+5,894
| +8% | +$146K |
|
5774
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.79B
| $1.83M | ﹤0.01% |
23,552
+19,446
| +474% | +$1.53M |
|
5775
iShares MSCI Singapore ETF
EWS
$1.23B
| $1.83M | ﹤0.01% |
83,942
+67,794
| +420% | +$1.5M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.